Substrate specificity and inhibitor profile of human recombinant p56(lck) from a baculovirus expression vector

被引:4
作者
Flotow, H
Purton, TJ
Whitaker, DP
Williams, DH
Wilkinson, SE
机构
[1] Roche Research Centre, Welwyn Garden City, Herts, Broadwater Road
关键词
p56(lck); peptide; substrate; inhibitors;
D O I
10.1007/BF02252937
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p56(lck), a member of the src family of nonreceptor protein receptor kinases, is required for normal signal transduction through the T cell receptor, Inappropriate T cell activation and proliferation has been identified as an early event in auto-immune disease - agents which control T cell activation through modulation of p56(lck) kinase activity could therefore be potential therapeutic agents for a range of pathological conditions, To identify p56(lck) inhibitors, we have established an assay system suitable for the high throughput screening of compound libraries, The assay uses enzyme purified from baculovirus infected SF9 cells, and a novel peptidic substrate identified by L. Cantley from a degenerate combinatorial peptide Library. We have used this assay system to screen a number elf different compounds as potential inhibitors of p56(lck), In addition, peptides based on the substrate sequence were also tested to identify a sequence that could be used in the rational design of peptide inhibitors of p56(lck).
引用
收藏
页码:412 / 415
页数:4
相关论文
共 13 条
[1]   BICYCLIC COMPOUNDS AS RING-CONSTRAINED INHIBITORS OF PROTEIN-TYROSINE KINASE-P56LCK [J].
BURKE, TR ;
LIM, B ;
MARQUEZ, VE ;
LI, ZH ;
BOLEN, JB ;
STEFANOVA, I ;
HORAK, ID .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (04) :425-432
[2]   LCK UNIQUE DOMAIN INFLUENCES LCK SPECIFICITY AND BIOLOGICAL FUNCTION [J].
CARRERA, AC ;
PARADIS, H ;
BORLADO, LR ;
ROBERTS, TM ;
MARTINEZ, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (07) :3385-3391
[3]   ZAP-70 - A 70 KD PROTEIN-TYROSINE KINASE THAT ASSOCIATES WITH THE TCR ZETA-CHAIN [J].
CHAN, AC ;
IWASHIMA, M ;
TURCK, CW ;
WEISS, A .
CELL, 1992, 71 (04) :649-662
[4]  
CHAN AC, 1994, J IMMUNOL, V152, P4758
[5]  
CURREY HLF, 1978, COPEMNAS TXB RHEUMAT
[6]   TYRPHOSTINS .2. HETEROCYCLIC AND ALPHA-SUBSTITUTED BENZYLIDENEMALONONITRILE TYRPHOSTINS AS POTENT INHIBITORS OF EGF RECEPTOR AND ERBB2/NEU TYROSINE KINASES [J].
GAZIT, A ;
OSHEROV, N ;
POSNER, I ;
YAISH, P ;
PORADOSU, E ;
GILON, C ;
LEVITZKI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (06) :1896-1907
[7]   ROLE OF TYROSINE KINASES IN LYMPHOCYTE-ACTIVATION - TARGETS FOR DRUG INTERVENTION [J].
HANKE, JH ;
POLLOK, BA ;
CHANGELIAN, PS .
INFLAMMATION RESEARCH, 1995, 44 (09) :357-371
[8]   PROFOUND BLOCK IN THYMOCYTE DEVELOPMENT IN MICE LACKING P56(LCK) [J].
MOLINA, TJ ;
KISHIHARA, K ;
SIDEROVSKI, DP ;
VANEWIJK, W ;
NARENDRAN, A ;
TIMMS, E ;
WAKEHAM, A ;
PAIGE, CJ ;
HARTMANN, KU ;
VEILLETTE, A ;
DAVIDSON, D ;
MAK, TW .
NATURE, 1992, 357 (6374) :161-164
[9]   MODULATION OF CELLULAR PROCESSES BY H7, A NONSELECTIVE INHIBITOR OF PROTEIN-KINASES [J].
NIXON, JS ;
WILKINSON, SE ;
DAVIS, PD ;
SEDGWICK, AD ;
WADSWORTH, J ;
WESTMACOTT, D .
AGENTS AND ACTIONS, 1991, 32 (3-4) :188-193
[10]  
PERLMUTTER RM, 1988, BIOCHIM BIOPHYS ACTA, V948, P25